Featured Events
CBI Live
Latest News
View a recent blog posting from Pharmaceutical Executive and learn how industry stakeholders are managing Patient Adherence.
For more information on the...
In its Fiscal year (FY) 2011, FDA approved 35 new molecular entities (NMEs). Rare or so-called “orphan” diseases (affects <200,000 persons...
The winners for the 7th Annual Strategic Patient Adherence Awards have been chosen! The awards, co-sponsored by CBI and Pharmaceutical Executive...
A key to streamlining clinical trials is lessoning the reliance on paper processes. A well-designed and implemented portal offers this opportunity...
CMS has extended the deadline for collecting Sunshine Data to January, 2013. Read the CMS Blog here.
Attendance at CBI's Sunshine and Aggregate...
Blog - Remembering Krebiozen: Why We Have Access to Unapproved Drugs and Why We Need Scientific Evidence By: Richard Pazdur, M.D. >>read blog
MEET THE NEW LEADERSHIP AT CBI’S 7TH ANNUAL PHARMA, BIOTECH and DEVICE CORPORATE TAX CONGRESS– JUNE 6-7, 2012 IN WASHINGTON, D.C.
April 26,...
Stephanie Gilson, Assistant General Counsel, Johnson & Johnson is speaking at CBI’s upcoming 5th Bio/Pharmaceutical Summit on Managed...

